Influence of cholinergic system on myoclonus in myoclonic epilepsies
Identifieur interne : 009291 ( Main/Merge ); précédent : 009290; suivant : 009292Influence of cholinergic system on myoclonus in myoclonic epilepsies
Auteurs : Rektor [Tchécoslovaquie] ; Milada Švejdová [France] ; Carmen Silva-Barrat [Tchécoslovaquie] ; Christian Menini [France]Source :
- Movement Disorders [ 0885-3185 ] ; 1992.
English descriptors
- KwdEn :
- Adolescent, Adult, Atropine, Atropine (diagnostic use), Cerebral Cortex (drug effects), Cerebral Cortex (physiopathology), Cholinergic Fibers (drug effects), Cholinergic Fibers (physiology), Cholinergic system, Dose-Response Relationship, Drug, Electroencephalography (drug effects), Electromyography (drug effects), Epilepsies, Myoclonic (physiopathology), Female, Humans, Male, Middle Aged, Myoclonic epilepsies, Myoclonus, Physostigmine, Physostigmine (diagnostic use), Receptors, Cholinergic (drug effects), Receptors, Cholinergic (physiology), Single-Blind Method.
- MESH :
- chemical , diagnostic use : Atropine, Physostigmine.
- drug effects : Cerebral Cortex, Cholinergic Fibers, Electroencephalography, Electromyography, Receptors, Cholinergic.
- physiology : Cholinergic Fibers, Receptors, Cholinergic.
- physiopathology : Cerebral Cortex, Epilepsies, Myoclonic.
- Adolescent, Adult, Dose-Response Relationship, Drug, Female, Humans, Male, Middle Aged, Single-Blind Method.
Abstract
The effect of two drugs upon multifocal myoclonic jerks was evaluated. The drugs influence the central cholinergic system in opposite ways. Eight patients with progressive and nonprogressive myoclonic epilepsy were tested. The single blind test was used. The number of myoclonic jerks after intravenous physostigmine (mean dose 0.02 mg/kg) and that after atropine (0.04 mg/kg) was compared to number of myoclonic jerks in the drug‐free periods and with placebo. Placebo was without an effect. Physostigmine slightly increased the number of jerks. Atropine decreased the number significantly. In most patients the results were not striking. It is suggested that the cholinergic system may participate in the physiopathology of the studied myoclonic in a rather indirect, perhaps modulating way.
Url:
DOI: 10.1002/mds.870070306
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: 003427
- to stream Istex, to step Curation: 003427
- to stream Istex, to step Checkpoint: 004201
- to stream PubMed, to step Corpus: 004D34
- to stream PubMed, to step Curation: 004D34
- to stream PubMed, to step Checkpoint: 004D40
- to stream Ncbi, to step Merge: 001456
- to stream Ncbi, to step Curation: 001456
- to stream Ncbi, to step Checkpoint: 001456
Links to Exploration step
ISTEX:BC64EC5D09D283F16F193AB707057FD7D27C3CACLe document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Influence of cholinergic system on myoclonus in myoclonic epilepsies</title>
<author><name sortKey="Rektor" sort="Rektor" uniqKey="Rektor" last="Rektor">Rektor</name>
</author>
<author><name sortKey="Svejdova, Milada" sort="Svejdova, Milada" uniqKey="Svejdova M" first="Milada" last="Švejdová">Milada Švejdová</name>
</author>
<author><name sortKey="Silva Arrat, Carmen" sort="Silva Arrat, Carmen" uniqKey="Silva Arrat C" first="Carmen" last="Silva-Barrat">Carmen Silva-Barrat</name>
</author>
<author><name sortKey="Menini, Christian" sort="Menini, Christian" uniqKey="Menini C" first="Christian" last="Menini">Christian Menini</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:BC64EC5D09D283F16F193AB707057FD7D27C3CAC</idno>
<date when="1992" year="1992">1992</date>
<idno type="doi">10.1002/mds.870070306</idno>
<idno type="url">https://api.istex.fr/document/BC64EC5D09D283F16F193AB707057FD7D27C3CAC/fulltext/pdf</idno>
<idno type="wicri:Area/Istex/Corpus">003427</idno>
<idno type="wicri:Area/Istex/Curation">003427</idno>
<idno type="wicri:Area/Istex/Checkpoint">004201</idno>
<idno type="wicri:doubleKey">0885-3185:1992:Rektor:influence:of:cholinergic</idno>
<idno type="wicri:source">PubMed</idno>
<idno type="RBID">pubmed:1620139</idno>
<idno type="wicri:Area/PubMed/Corpus">004D34</idno>
<idno type="wicri:Area/PubMed/Curation">004D34</idno>
<idno type="wicri:Area/PubMed/Checkpoint">004D40</idno>
<idno type="wicri:Area/Ncbi/Merge">001456</idno>
<idno type="wicri:Area/Ncbi/Curation">001456</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">001456</idno>
<idno type="wicri:doubleKey">0885-3185:1992:Rektor I:influence:of:cholinergic</idno>
<idno type="wicri:Area/Main/Merge">009291</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Influence of cholinergic system on myoclonus in myoclonic epilepsies</title>
<author><name sortKey="Rektor" sort="Rektor" uniqKey="Rektor" last="Rektor">Rektor</name>
<affiliation wicri:level="3"><country xml:lang="fr">Tchécoslovaquie</country>
<wicri:regionArea>Clinic of Neurology, Masaryk University, Brno</wicri:regionArea>
<placeName><settlement type="city">Brno</settlement>
<region>Moravie</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Svejdova, Milada" sort="Svejdova, Milada" uniqKey="Svejdova M" first="Milada" last="Švejdová">Milada Švejdová</name>
<affiliation wicri:level="1"><country xml:lang="fr">France</country>
<wicri:regionArea>C.N.R.S., Laboratoire de Physiologie Nerveuse, Gif‐sur‐Yvette</wicri:regionArea>
<wicri:noRegion>Gif‐sur‐Yvette</wicri:noRegion>
<wicri:noRegion>Gif‐sur‐Yvette</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Silva Arrat, Carmen" sort="Silva Arrat, Carmen" uniqKey="Silva Arrat C" first="Carmen" last="Silva-Barrat">Carmen Silva-Barrat</name>
<affiliation wicri:level="3"><country xml:lang="fr">Tchécoslovaquie</country>
<wicri:regionArea>Clinic of Neurology, Masaryk University, Brno</wicri:regionArea>
<placeName><settlement type="city">Brno</settlement>
<region>Moravie</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Menini, Christian" sort="Menini, Christian" uniqKey="Menini C" first="Christian" last="Menini">Christian Menini</name>
<affiliation wicri:level="1"><country xml:lang="fr">France</country>
<wicri:regionArea>C.N.R.S., Laboratoire de Physiologie Nerveuse, Gif‐sur‐Yvette</wicri:regionArea>
<wicri:noRegion>Gif‐sur‐Yvette</wicri:noRegion>
<wicri:noRegion>Gif‐sur‐Yvette</wicri:noRegion>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series><title level="j">Movement Disorders</title>
<title level="j" type="sub">Official Journal of the Movement Disorder Society</title>
<title level="j" type="abbrev">Mov. Disord.</title>
<idno type="ISSN">0885-3185</idno>
<idno type="eISSN">1531-8257</idno>
<imprint><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher>
<pubPlace>Hoboken</pubPlace>
<date type="published" when="1992">1992</date>
<biblScope unit="vol">7</biblScope>
<biblScope unit="issue">3</biblScope>
<biblScope unit="page" from="224">224</biblScope>
<biblScope unit="page" to="227">227</biblScope>
</imprint>
<idno type="ISSN">0885-3185</idno>
</series>
<idno type="istex">BC64EC5D09D283F16F193AB707057FD7D27C3CAC</idno>
<idno type="DOI">10.1002/mds.870070306</idno>
<idno type="ArticleID">MDS870070306</idno>
</biblStruct>
</sourceDesc>
<seriesStmt><idno type="ISSN">0885-3185</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adolescent</term>
<term>Adult</term>
<term>Atropine</term>
<term>Atropine (diagnostic use)</term>
<term>Cerebral Cortex (drug effects)</term>
<term>Cerebral Cortex (physiopathology)</term>
<term>Cholinergic Fibers (drug effects)</term>
<term>Cholinergic Fibers (physiology)</term>
<term>Cholinergic system</term>
<term>Dose-Response Relationship, Drug</term>
<term>Electroencephalography (drug effects)</term>
<term>Electromyography (drug effects)</term>
<term>Epilepsies, Myoclonic (physiopathology)</term>
<term>Female</term>
<term>Humans</term>
<term>Male</term>
<term>Middle Aged</term>
<term>Myoclonic epilepsies</term>
<term>Myoclonus</term>
<term>Physostigmine</term>
<term>Physostigmine (diagnostic use)</term>
<term>Receptors, Cholinergic (drug effects)</term>
<term>Receptors, Cholinergic (physiology)</term>
<term>Single-Blind Method</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="diagnostic use" xml:lang="en"><term>Atropine</term>
<term>Physostigmine</term>
</keywords>
<keywords scheme="MESH" qualifier="drug effects" xml:lang="en"><term>Cerebral Cortex</term>
<term>Cholinergic Fibers</term>
<term>Electroencephalography</term>
<term>Electromyography</term>
<term>Receptors, Cholinergic</term>
</keywords>
<keywords scheme="MESH" qualifier="physiology" xml:lang="en"><term>Cholinergic Fibers</term>
<term>Receptors, Cholinergic</term>
</keywords>
<keywords scheme="MESH" qualifier="physiopathology" xml:lang="en"><term>Cerebral Cortex</term>
<term>Epilepsies, Myoclonic</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Adolescent</term>
<term>Adult</term>
<term>Dose-Response Relationship, Drug</term>
<term>Female</term>
<term>Humans</term>
<term>Male</term>
<term>Middle Aged</term>
<term>Single-Blind Method</term>
</keywords>
</textClass>
<langUsage><language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">The effect of two drugs upon multifocal myoclonic jerks was evaluated. The drugs influence the central cholinergic system in opposite ways. Eight patients with progressive and nonprogressive myoclonic epilepsy were tested. The single blind test was used. The number of myoclonic jerks after intravenous physostigmine (mean dose 0.02 mg/kg) and that after atropine (0.04 mg/kg) was compared to number of myoclonic jerks in the drug‐free periods and with placebo. Placebo was without an effect. Physostigmine slightly increased the number of jerks. Atropine decreased the number significantly. In most patients the results were not striking. It is suggested that the cholinergic system may participate in the physiopathology of the studied myoclonic in a rather indirect, perhaps modulating way.</div>
</front>
</TEI>
<double doi="10.1002/mds.870070306"><ISTEX><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Influence of cholinergic system on myoclonus in myoclonic epilepsies</title>
<author><name sortKey="Rektor" sort="Rektor" uniqKey="Rektor" last="Rektor">Rektor</name>
</author>
<author><name sortKey="Svejdova, Milada" sort="Svejdova, Milada" uniqKey="Svejdova M" first="Milada" last="Švejdová">Milada Švejdová</name>
</author>
<author><name sortKey="Silva Arrat, Carmen" sort="Silva Arrat, Carmen" uniqKey="Silva Arrat C" first="Carmen" last="Silva-Barrat">Carmen Silva-Barrat</name>
</author>
<author><name sortKey="Menini, Christian" sort="Menini, Christian" uniqKey="Menini C" first="Christian" last="Menini">Christian Menini</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:BC64EC5D09D283F16F193AB707057FD7D27C3CAC</idno>
<date when="1992" year="1992">1992</date>
<idno type="doi">10.1002/mds.870070306</idno>
<idno type="url">https://api.istex.fr/document/BC64EC5D09D283F16F193AB707057FD7D27C3CAC/fulltext/pdf</idno>
<idno type="wicri:Area/Istex/Corpus">003427</idno>
<idno type="wicri:Area/Istex/Curation">003427</idno>
<idno type="wicri:Area/Istex/Checkpoint">004201</idno>
<idno type="wicri:doubleKey">0885-3185:1992:Rektor:influence:of:cholinergic</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Influence of cholinergic system on myoclonus in myoclonic epilepsies</title>
<author><name sortKey="Rektor" sort="Rektor" uniqKey="Rektor" last="Rektor">Rektor</name>
<affiliation wicri:level="3"><country xml:lang="fr">Tchécoslovaquie</country>
<wicri:regionArea>Clinic of Neurology, Masaryk University, Brno</wicri:regionArea>
<placeName><settlement type="city">Brno</settlement>
<region>Moravie</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Svejdova, Milada" sort="Svejdova, Milada" uniqKey="Svejdova M" first="Milada" last="Švejdová">Milada Švejdová</name>
<affiliation wicri:level="1"><country xml:lang="fr">France</country>
<wicri:regionArea>C.N.R.S., Laboratoire de Physiologie Nerveuse, Gif‐sur‐Yvette</wicri:regionArea>
<wicri:noRegion>Gif‐sur‐Yvette</wicri:noRegion>
<wicri:noRegion>Gif‐sur‐Yvette</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Silva Arrat, Carmen" sort="Silva Arrat, Carmen" uniqKey="Silva Arrat C" first="Carmen" last="Silva-Barrat">Carmen Silva-Barrat</name>
<affiliation wicri:level="3"><country xml:lang="fr">Tchécoslovaquie</country>
<wicri:regionArea>Clinic of Neurology, Masaryk University, Brno</wicri:regionArea>
<placeName><settlement type="city">Brno</settlement>
<region>Moravie</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Menini, Christian" sort="Menini, Christian" uniqKey="Menini C" first="Christian" last="Menini">Christian Menini</name>
<affiliation wicri:level="1"><country xml:lang="fr">France</country>
<wicri:regionArea>C.N.R.S., Laboratoire de Physiologie Nerveuse, Gif‐sur‐Yvette</wicri:regionArea>
<wicri:noRegion>Gif‐sur‐Yvette</wicri:noRegion>
<wicri:noRegion>Gif‐sur‐Yvette</wicri:noRegion>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series><title level="j">Movement Disorders</title>
<title level="j" type="sub">Official Journal of the Movement Disorder Society</title>
<title level="j" type="abbrev">Mov. Disord.</title>
<idno type="ISSN">0885-3185</idno>
<idno type="eISSN">1531-8257</idno>
<imprint><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher>
<pubPlace>Hoboken</pubPlace>
<date type="published" when="1992">1992</date>
<biblScope unit="vol">7</biblScope>
<biblScope unit="issue">3</biblScope>
<biblScope unit="page" from="224">224</biblScope>
<biblScope unit="page" to="227">227</biblScope>
</imprint>
<idno type="ISSN">0885-3185</idno>
</series>
<idno type="istex">BC64EC5D09D283F16F193AB707057FD7D27C3CAC</idno>
<idno type="DOI">10.1002/mds.870070306</idno>
<idno type="ArticleID">MDS870070306</idno>
</biblStruct>
</sourceDesc>
<seriesStmt><idno type="ISSN">0885-3185</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Atropine</term>
<term>Cholinergic system</term>
<term>Myoclonic epilepsies</term>
<term>Myoclonus</term>
<term>Physostigmine</term>
</keywords>
</textClass>
<langUsage><language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">The effect of two drugs upon multifocal myoclonic jerks was evaluated. The drugs influence the central cholinergic system in opposite ways. Eight patients with progressive and nonprogressive myoclonic epilepsy were tested. The single blind test was used. The number of myoclonic jerks after intravenous physostigmine (mean dose 0.02 mg/kg) and that after atropine (0.04 mg/kg) was compared to number of myoclonic jerks in the drug‐free periods and with placebo. Placebo was without an effect. Physostigmine slightly increased the number of jerks. Atropine decreased the number significantly. In most patients the results were not striking. It is suggested that the cholinergic system may participate in the physiopathology of the studied myoclonic in a rather indirect, perhaps modulating way.</div>
</front>
</TEI>
</ISTEX>
<PubMed><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Influence of cholinergic system on myoclonus in myoclonic epilepsies.</title>
<author><name sortKey="Rektor, I" sort="Rektor, I" uniqKey="Rektor I" first="I" last="Rektor">I. Rektor</name>
<affiliation wicri:level="3"><nlm:affiliation>Clinic of Neurology, Masaryk University, Brno, Czechoslovakia.</nlm:affiliation>
<country xml:lang="fr">Tchécoslovaquie</country>
<wicri:regionArea>Clinic of Neurology, Masaryk University, Brno</wicri:regionArea>
<placeName><settlement type="city">Brno</settlement>
<region>Moravie</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Svejdova, M" sort="Svejdova, M" uniqKey="Svejdova M" first="M" last="Svejdová">M. Svejdová</name>
</author>
<author><name sortKey="Silva Barrat, C" sort="Silva Barrat, C" uniqKey="Silva Barrat C" first="C" last="Silva-Barrat">C. Silva-Barrat</name>
</author>
<author><name sortKey="Menini, C" sort="Menini, C" uniqKey="Menini C" first="C" last="Menini">C. Menini</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="1992">1992</date>
<idno type="RBID">pubmed:1620139</idno>
<idno type="pmid">1620139</idno>
<idno type="doi">10.1002/mds.870070306</idno>
<idno type="wicri:Area/PubMed/Corpus">004D34</idno>
<idno type="wicri:Area/PubMed/Curation">004D34</idno>
<idno type="wicri:Area/PubMed/Checkpoint">004D40</idno>
<idno type="wicri:Area/Ncbi/Merge">001456</idno>
<idno type="wicri:Area/Ncbi/Curation">001456</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">001456</idno>
<idno type="wicri:doubleKey">0885-3185:1992:Rektor I:influence:of:cholinergic</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Influence of cholinergic system on myoclonus in myoclonic epilepsies.</title>
<author><name sortKey="Rektor, I" sort="Rektor, I" uniqKey="Rektor I" first="I" last="Rektor">I. Rektor</name>
<affiliation wicri:level="3"><nlm:affiliation>Clinic of Neurology, Masaryk University, Brno, Czechoslovakia.</nlm:affiliation>
<country xml:lang="fr">Tchécoslovaquie</country>
<wicri:regionArea>Clinic of Neurology, Masaryk University, Brno</wicri:regionArea>
<placeName><settlement type="city">Brno</settlement>
<region>Moravie</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Svejdova, M" sort="Svejdova, M" uniqKey="Svejdova M" first="M" last="Svejdová">M. Svejdová</name>
</author>
<author><name sortKey="Silva Barrat, C" sort="Silva Barrat, C" uniqKey="Silva Barrat C" first="C" last="Silva-Barrat">C. Silva-Barrat</name>
</author>
<author><name sortKey="Menini, C" sort="Menini, C" uniqKey="Menini C" first="C" last="Menini">C. Menini</name>
</author>
</analytic>
<series><title level="j">Movement disorders : official journal of the Movement Disorder Society</title>
<idno type="ISSN">0885-3185</idno>
<imprint><date when="1992" type="published">1992</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adolescent</term>
<term>Adult</term>
<term>Atropine (diagnostic use)</term>
<term>Cerebral Cortex (drug effects)</term>
<term>Cerebral Cortex (physiopathology)</term>
<term>Cholinergic Fibers (drug effects)</term>
<term>Cholinergic Fibers (physiology)</term>
<term>Dose-Response Relationship, Drug</term>
<term>Electroencephalography (drug effects)</term>
<term>Electromyography (drug effects)</term>
<term>Epilepsies, Myoclonic (physiopathology)</term>
<term>Female</term>
<term>Humans</term>
<term>Male</term>
<term>Middle Aged</term>
<term>Physostigmine (diagnostic use)</term>
<term>Receptors, Cholinergic (drug effects)</term>
<term>Receptors, Cholinergic (physiology)</term>
<term>Single-Blind Method</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="diagnostic use" xml:lang="en"><term>Atropine</term>
<term>Physostigmine</term>
</keywords>
<keywords scheme="MESH" qualifier="drug effects" xml:lang="en"><term>Cerebral Cortex</term>
<term>Cholinergic Fibers</term>
<term>Electroencephalography</term>
<term>Electromyography</term>
<term>Receptors, Cholinergic</term>
</keywords>
<keywords scheme="MESH" qualifier="physiology" xml:lang="en"><term>Cholinergic Fibers</term>
<term>Receptors, Cholinergic</term>
</keywords>
<keywords scheme="MESH" qualifier="physiopathology" xml:lang="en"><term>Cerebral Cortex</term>
<term>Epilepsies, Myoclonic</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Adolescent</term>
<term>Adult</term>
<term>Dose-Response Relationship, Drug</term>
<term>Female</term>
<term>Humans</term>
<term>Male</term>
<term>Middle Aged</term>
<term>Single-Blind Method</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">The effect of two drugs upon multifocal myoclonic jerks was evaluated. The drugs influence the central cholinergic system in opposite ways. Eight patients with progressive and nonprogressive myoclonic epilepsy were tested. The single blind test was used. The number of myoclonic jerks after intravenous physostigmine (mean dose 0.02 mg/kg) and that after atropine (0.04 mg/kg) was compared to number of myoclonic jerks in the drug-free periods and with placebo. Placebo was without an effect. Physostigmine slightly increased the number of jerks. Atropine decreased the number significantly. In most patients the results were not striking. It is suggested that the cholinergic system may participate in the physiopathology of the studied myoclonus in a rather indirect, perhaps modulating way.</div>
</front>
</TEI>
</PubMed>
</double>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Main/Merge
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 009291 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Merge/biblio.hfd -nk 009291 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Santé |area= MovDisordV3 |flux= Main |étape= Merge |type= RBID |clé= ISTEX:BC64EC5D09D283F16F193AB707057FD7D27C3CAC |texte= Influence of cholinergic system on myoclonus in myoclonic epilepsies }}
This area was generated with Dilib version V0.6.23. |